Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV)
CMV-IGIV is a purified immunoglobulin fraction from human plasma of donors with high CMV antibody titers, used prophylactically in transplant patients. It is classified under HTS 3002.12.00 as other blood fractions for therapeutic use. The product prevents CMV infection through passive antibody transfer.
Import Duty Rates by Country of Origin
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If put up in measured doses for direct patient administration as a kit
Heading 3006 covers specific pharmaceutical forms like measured-dose opacifying or diagnostic kits.
If for hormone-based components if extracted and not blood-derived
Certain hormonal products shift to Chapter 29 if not qualifying as blood fractions.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Ensure compliance with 21 CFR 640.100 for immune globulin imports
• Document pathogen reduction steps to satisfy biosecurity import checks
• Use tamper-evident packaging to prevent tampering claims at inspection
Related Products under HTS 3002.12.00
Human Anti-D Immunoglobulin
This is a blood fraction derived from human plasma containing antibodies against the D antigen on red blood cells, used prophylactically to prevent Rh incompatibility in pregnancies. It qualifies under HTS 3002.12.00 as an antiserum and blood fraction prepared for therapeutic or prophylactic use. The product is obtained through plasma fractionation and purification processes.
Human Immunoglobulin G (IgG) Intravenous
IVIG is a pooled blood fraction from human plasma containing primarily IgG antibodies, used therapeutically for immune deficiencies and autoimmune disorders. It is classified under HTS 3002.12.00 as other blood fractions prepared for therapeutic uses via biotechnological purification. This sterile, high-purity product replaces missing antibodies in patients.
Rabies Immune Globulin (Human)
This human-derived antiserum provides passive immunity against rabies virus post-exposure, consisting of purified IgG antibodies from vaccinated donors. Classified in HTS 3002.12.00 as antisera and blood fractions for prophylactic use. It is administered intramuscularly alongside vaccine for high-risk exposures.
Tetanus Immune Globulin (Human)
A human blood fraction containing high-titer antibodies against tetanus toxin, used for passive immunization in wound management. Falls under HTS 3002.12.00 as antisera prepared for therapeutic and prophylactic purposes. It is sterile and lyophilized for intramuscular injection.
Hepatitis B Immune Globulin (HBIG)
HBIG is a human plasma-derived blood fraction rich in antibodies to hepatitis B surface antigen, used for post-exposure prophylaxis. Under HTS 3002.12.00 as antisera for therapeutic and prophylactic applications. It provides immediate protection in high-risk scenarios like needlestick injuries.
Botulism Antitoxin (Trivalent, Equine)
This equine-derived antiserum neutralizes botulinum neurotoxins A, B, and E, used therapeutically for botulism poisoning. Classified in HTS 3002.12.00 as antisera prepared for therapeutic uses, including animal blood sources. It is purified to reduce hypersensitivity risks.